Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine October 2013, 54 (10) 7A;
  • Article
  • Info & Metrics
  • PDF
Loading

PET and prostate cancer: Jadvar provides perspective on the current status of molecular imaging of prostate cancer with PET, including assessment of a range of radiotracers and prospects for future development.

Page 1685

Response criteria in PRRT: van Vliet and colleagues compare tumor response assessment using 4 common criteria in patients with neuroendocrine tumors treated with 177Lu-octreotate peptide receptor radionuclide therapy.

Page 1689

PET in breast cancer: Gemignani and colleagues describe correlation of 18F-FES PET with expression of estrogen and progesterone receptors in patients with primary, operable breast cancer.

Page 1697

Textural features in oropharyngeal cancer: Cheng and colleagues determine whether textural features in pretreatment 18F-FDG PET/CT can provide additional prognostic information over total lesion glycolysis and clinical staging in advanced oropharyngeal squamous cell carcinoma.

Page 1703

PET, ablative radiotherapy, and HCC: Huang and colleagues explore the utility of 18F-FDG PET and a combined 18F-FDG–contrast CT parameter for predicting tumor control in patients with hepatocellular carcinoma treated with stereotactic ablative radiotherapy.

Page 1710

99mTc-sestamibi and Gaucher disease: Erba and colleagues investigate the reliability of 99mTc-sestamibi scintigraphy in monitoring changes in bone marrow involvement induced by enzyme replacement therapy in patients with Gaucher disease.

Page 1717

PET and survival in osteosarcoma: Byun and colleagues explore the ability of metabolic and volumetric parameters on pretreatment 18F-FDG PET/CT as well as histologic and chemotherapeutic response to predict survival in patients with osteosarcoma of the extremities.

Page 1725

β-blockers and hemostasis in heart failure: de Peuter and colleagues use 123I-MIBG imaging to compare cardiac sympathetic activity with selective and nonselective β-blockers in patients with heart failure and correlate results with serum markers for coagulability.

Page 1733

PET and abdominal aortic aneurysms: Courtois and colleagues compare 18F-FDG uptake in aneurysmal wall biopsies from patients with abdominal aortic aneurysms to determine whether PET can identify cellular and molecular changes predictive of deterioration and rupture.

Page 1740

Regadenoson 82Rb cardiac PET: Hsiao and colleagues explore the diagnostic performance of regadenoson 82Rb myocardial perfusion PET imaging in detection of obstructive coronary artery disease in patients with and without pretest likelihood of cardiac disease.

Page 1748

68Ga-DOTATOC and 68Ga-DOTATATE dosimetry: Sandström and colleagues document the comparative biodistributions and radiation dosimetry of these radiolabeled somatostatin analogs for PET imaging in patients with neuroendocrine tumors.

Page 1755

Novel A2A receptor tracer: Tavares and colleagues describe the kinetic properties, test–retest results, and dosimetry estimates of a 123I-labeled SPECT tracer for in vivo imaging of adenosine 2A receptors in the brain.

Page 1760

Improved AC for PET/MR: Bezrukov and colleagues assess the accuracy of 4 MR-based attenuation correction techniques for hybrid PET/MR imaging in lesions within soft tissue, bone, and MR susceptibility artifacts.

Page 1768

Radionuclide imaging in epilepsy: Kumar and Chugani provide an educational overview of current applications of PET and SPECT in presurgical evaluation of intractable seizures, including localizing epileptogenic regions, identifying dual pathologies, assessing secondary foci, and evaluating brain functional integrity.

Page 1775

Alternative to mice in tracer development: Warnock and colleagues demonstrate PET and CT imaging in a U87 glioblastoma tumor model grown on chicken chorioallantoic membranes as a rapid, inexpensive, and ethically sustainable alternative to mice in novel PET tracer research.

Page 1782

PulmoBind lung imaging: Létourneau and colleagues detail the design of and early translational studies with a 99mTc-labeled adrenomedullin-based compound for molecular imaging of the pulmonary circulation.

Page 1789

99mTc GRPs in tumor imaging: Marsouvanidis and colleagues detail the development of a series of 99mTc-labeled demomedin C analogs and compare their performance in both in vitro and in vivo gastrin-releasing peptide receptor tumor models.

Page 1797

Metabolism of 11C-PD153035: Samén and colleagues investigate the in vivo metabolic characteristics of this analog of an epidermal growth factor receptor tyrosine kinase inhibitor to determine whether alterations in metabolite formation are accompanied by changes in biodistribution and tumor uptake.

Page 1804

PET-compatible tissue bioreactor: Whitehead and colleagues detail the development of a tissue bioreactor enabling modulation of the microenvironment and integration of the reactor with a small-animal PET scanner to facilitate imaging biomarker and radiopharmaceutical research.

Page 1812

Microfluidic radioassay: Wang and colleagues describe the development and use of a portable radiopharmaceutical imaging platform designed to capture the kinetics of cellular responses to drugs.

Page 1820

nanoScan PET/MR performance: Nagy and colleagues evaluate the standards-based performance of this high-resolution integrated system for consecutive PET and MR imaging of small laboratory animals.

Page 1825

Inveon SPECT capabilities: Boisson and colleagues assess the performance metrics of this small-animal system using 3 dedicated collimators for imaging in mice and 3 for rats.

Page 1833

Radioluminescence microscopy and 18F-FDG uptake: Pratx and colleague report on a particle-counting method for improving spatial resolution and overcoming β-range limits in fluorescence microscopy imaging of radionuclide uptake by single cells.

Page 1841

  • © 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 54 (10)
Journal of Nuclear Medicine
Vol. 54, Issue 10
October 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Oct 2013, 54 (10) 7A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Oct 2013, 54 (10) 7A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Initial Metabolic Tumor Volume Measured by 18F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities
  • Fast Metabolic Response to Drug Intervention Through Analysis on a Miniaturized, Highly Integrated Molecular Imaging System
  • The Role of Radionuclide Imaging in Epilepsy, Part 1: Sporadic Temporal and Extratemporal Lobe Epilepsy
  • Performance Evaluation of the Small-Animal nanoScan PET/MRI System
  • High-Resolution Radioluminescence Microscopy of 18F-FDG Uptake by Reconstructing the β-Ionization Track
  • Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans
  • Detection of Obstructive Coronary Artery Disease Using Regadenoson Stress and 82Rb PET/CT Myocardial Perfusion Imaging
  • 99mTc Radiotracers Based on Human GRP(18-27): Synthesis and Comparative Evaluation
  • Metabolism of Epidermal Growth Factor Receptor Targeting Probe [11C]PD153035: Impact on Biodistribution and Tumor Uptake in Rats
  • 18F-FDG Uptake Assessed by PET/CT in Abdominal Aortic Aneurysms Is Associated with Cellular and Molecular Alterations Prefacing Wall Deterioration and Rupture
  • PulmoBind, an Adrenomedullin-Based Molecular Lung Imaging Tool
  • Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer
  • Molecular Imaging of Prostate Cancer with PET
  • Imaging Capabilities of the Inveon SPECT System Using Single-and Multipinhole Collimators
  • 99mTc-Sestamibi Scintigraphy to Monitor the Long-Term Efficacy of Enzyme Replacement Therapy on Bone Marrow Infiltration in Patients with Gaucher Disease
  • Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
  • In Vivo PET/CT in a Human Glioblastoma Chicken Chorioallantoic Membrane Model: A New Tool for Oncology and Radiotracer Development
  • MR-Based Attenuation Correction Methods for Improved PET Quantification in Lesions Within Bone and Susceptibility Artifact Regions
  • A PET-Compatible Tissue Bioreactor for Research, Discovery, and Validation of Imaging Biomarkers and Radiopharmaceuticals: System Design and Proof-of-Concept Studies
  • Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma
  • Differential Effects of Nonselective Versus Selective β-Blockers on Cardiac Sympathetic Activity and Hemostasis in Patients with Heart Failure
  • Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [177Lu-DOTA0,Tyr3]Octreotate
  • 18F-FDG PET and Combined 18F-FDG–Contrast CT Parameters as Predictors of Tumor Control for Hepatocellular Carcinoma After Stereotactic Ablative Radiotherapy
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire